New Treatment for Neuropathy Arrives in the Middle East

Peripheral neuropathy, a common disease that includes pain and loss of feeling in the face, arms, legs, and torso, occurs most often in patients with diabetes and those in chemotherapy treatment.  The Dellon Institutes offer both testing and surgical treatment for patients with peripheral neuropathy.     Dubai, United Arab Emirates - 15 January, 2007 -- The Dellon Institutes have opened their first international location for the treatment of neuropathy in Dubai Healthcare City.  Dr. Lee Dellon, M.D. of the Johns Hopkins Medical Institutions is a world authority on nerve regeneration research and surgery.  The Dellon Institutes have seven locations in the United States. Dellon Institutes - Dubai is under the direction of John C. Bouillon MD, a Massachusetts orthopedic surgeon who trained at Johns Hopkins Hospital and has over 25 years of surgical experience.  He now sees patients with general orthopedic as well as neuropathic and diabetic foot problems.  He works in association with the Consultant Physicians and the Dr. Sulaiman Al-Habib Medical Center in Dubai Health Care City (04-362-2999).     The occurrence of diabetes, world-wide has been steadily rising due to changing dietary habits.  Neuropathy has been called “the most common disease you've never heard of…” by the Neuropathy Foundation of New York City. 

Fifty to 70 percent of people who have diabetes for over 20 years suffer from neuropathy.  It is one of the most common causes of morbidity and mortality in diabetic patients.  The loss of sensation caused by neuropathy often leads to foot ulcers which in turns lead to gangrene requiring amputation.  The incidence of diabetes in the Middle East has been depicted as epidemic by various authorities including the International Diabetes Federation.     Peripheral neuropathy, which may also be called diabetic neuropathy, includes many diseases and abnormalities of the nervous system.  It is the deterioration of these nerves which disrupts the body's ability to communicate with its muscles, organs, and tissues.  Patients with neuropathy experience many symptoms such as tingling, burning, or a sharp stabbing pain in the extremities.  Loss of balance and coordination as well as reduced feeling in the hands or feet are other common indications.   In addition to diabetes, neuropathy can be the result of autoimmune diseases, rheumatoid arthritis, lupus, medication side effects, alcoholism, or even sports injuries.  In the case of diabetics, neuropathy is frequently the result of a nerve compression which is aggravated by a build-up of sugar in the nerve fibers. 

This compression occurs in known nerve tunnels in the arms and legs and can be released by surgery. The result is immense relief for the patient. Diagnosis of neuropathy is achieved with the Pressure Specified Sensory Device™ (PSSD).  This device, which was developed by Dr. Dellon, detects the early stages of peripheral neuropathy before the patient's nerves have fully deteriorated.  It is this ability to pinpoint the extent of neuropathy early that gives the doctors an advantage in treating the disease.  Some patients will require surgery, some heat therapy, while others may just need modified shoes.   Patients with neuropathy say they lead challenging lives.  Many of them cannot walk at all.  They take pain killers every day.  They stumble and fall.  They cannot feel their feet.  They often get depressed because of their situation.  Traditionally, doctors give them very little hope. 

The surgical techniques of A. Lee Dellon MD have been performed over a thousand times in the United States during the last ten years.  The decompression of nerves in the legs, ankles, and feet has been shown to have a success rate of over 80 percent in peer reviewed medical research.    For additional information on the news in this release, please contact Brian Scipione at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or at +97150-515-7416.